JP2018521119A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521119A5
JP2018521119A5 JP2018515175A JP2018515175A JP2018521119A5 JP 2018521119 A5 JP2018521119 A5 JP 2018521119A5 JP 2018515175 A JP2018515175 A JP 2018515175A JP 2018515175 A JP2018515175 A JP 2018515175A JP 2018521119 A5 JP2018521119 A5 JP 2018521119A5
Authority
JP
Japan
Prior art keywords
methyl
isopropylthio
pyrazole
thiazol
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018515175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521119A (ja
JP6707630B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/035288 external-priority patent/WO2016196644A1/en
Publication of JP2018521119A publication Critical patent/JP2018521119A/ja
Publication of JP2018521119A5 publication Critical patent/JP2018521119A5/ja
Application granted granted Critical
Publication of JP6707630B2 publication Critical patent/JP6707630B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018515175A 2015-06-01 2016-06-01 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法 Expired - Fee Related JP6707630B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562169376P 2015-06-01 2015-06-01
US62/169,376 2015-06-01
PCT/US2016/035288 WO2016196644A1 (en) 2015-06-01 2016-06-01 Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

Publications (3)

Publication Number Publication Date
JP2018521119A JP2018521119A (ja) 2018-08-02
JP2018521119A5 true JP2018521119A5 (enExample) 2019-10-03
JP6707630B2 JP6707630B2 (ja) 2020-06-10

Family

ID=56118071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018515175A Expired - Fee Related JP6707630B2 (ja) 2015-06-01 2016-06-01 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法

Country Status (9)

Country Link
US (2) US10537558B2 (enExample)
EP (1) EP3303332A1 (enExample)
JP (1) JP6707630B2 (enExample)
CN (1) CN108349962A (enExample)
BR (1) BR112017025851A2 (enExample)
CA (1) CA3025492A1 (enExample)
IL (1) IL255898A (enExample)
MX (1) MX2017015456A (enExample)
WO (1) WO2016196644A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6707630B2 (ja) 2015-06-01 2020-06-10 バンタム、ファーマシューティカル、リミテッド、ライアビリティー、カンパニーBantam Pharmaceutical, Llc 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法
MX2019006299A (es) * 2016-11-30 2019-11-12 Bantam Pharmaceutical Llc Compuestos de pirazola sustituida y metodos para usarlos para el tratamiento de enfermedades hiperproliferativas.
JP2020513403A (ja) * 2016-11-30 2020-05-14 バンタム、ファーマシューティカル、リミテッド、ライアビリティー、カンパニーBantam Pharmaceutical, Llc 置換ピラゾールおよびピロール化合物の使用する方法ならびに過剰増殖性疾患の治療のための方法
WO2019189731A1 (ja) 2018-03-30 2019-10-03 住友化学株式会社 複素環化合物及びそれを含有する有害節足動物防除組成物
WO2019236966A2 (en) 2018-06-07 2019-12-12 Bantam Pharmaceutical, Llc Methods of treatment of cancer with substituted pyrrole and pyrazole compounds and diagnosis of cancers susceptible to treatment with substituted pyrrole and pyrazole compounds
EP3846793B1 (en) 2018-09-07 2024-01-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof
CN110950848B (zh) * 2018-09-27 2024-03-26 徐诺药业 新型氨基吡唑类衍生物的合成与应用
JP2022535228A (ja) * 2019-05-31 2022-08-05 バンタム、ファーマシューティカル、リミテッド、ライアビリティー、カンパニー チアゾリルピラゾールカルボン酸の製造方法およびそれらのための中間体
CN114502551B (zh) 2019-11-01 2023-08-22 优迈特株式会社 含氟嘧啶化合物及其制备方法
AR121506A1 (es) 2020-03-03 2022-06-08 Pic Therapeutics Inc Inhibidores del eif4e y sus usos
US12157732B2 (en) 2021-08-25 2024-12-03 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof
IL310924A (en) 2021-08-25 2024-04-01 Pic Therapeutics Inc Eif4e inhibitors and uses thereof
WO2026152086A1 (en) 2025-01-10 2026-07-16 Bantam Pharmaceutical, Llc Pharmaceutical combinations of oma1 activators with bh3 mimetics

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342851A (en) * 1992-10-07 1994-08-30 Mcneil-Ppc, Inc. Substituted thiazole derivatives useful as platelet aggregation inhibitors
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
TR200302047T4 (tr) * 1999-12-03 2004-01-21 Pfizer Products Inc. Anti-iltihabik / analjezik maddeler olarak heteroaril fenil pirazol bileşikleri.
WO2003084544A2 (en) * 2002-04-04 2003-10-16 Cv Therapeutics, Inc. Compounds dor increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis
EP1613614A2 (en) 2003-04-03 2006-01-11 Merck & Co., Inc. Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
CA2522476A1 (en) * 2003-04-18 2004-11-04 Merck & Co., Inc. Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
WO2007138110A2 (en) * 2006-06-01 2007-12-06 Devgen N.V. Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2008121861A2 (en) 2007-03-28 2008-10-09 Xenon Pharmaceuticals Inc. Pyrazole and pyrrole compounds useful in treating iron disorders
ES2423932T3 (es) * 2007-08-27 2013-09-25 Basf Se Compuestos de pirazol para controlar plagas de invertebrados
CN102056907B (zh) * 2008-04-04 2014-12-31 武田药品工业株式会社 杂环衍生物及其用途
CN102089291B (zh) 2008-04-28 2016-08-17 杏林制药株式会社 环戊基丙烯酰胺衍生物
EP2651405A2 (en) * 2010-12-14 2013-10-23 Electrophoretics Limited Casein kinase 1 (ck1 ) inhibitors
US9409901B2 (en) 2012-10-22 2016-08-09 Bantam Pharmaceutical, Llc Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E
WO2015144290A1 (en) 2014-03-27 2015-10-01 Merck Patent Gmbh Pyridyl piperidines
ES2762947T3 (es) 2015-04-24 2020-05-26 Syngenta Participations Ag Derivados policíclicos con actividad plaguicida con anillos heterocíclicos de cinco miembros sustituidos con azufre
JP6707630B2 (ja) 2015-06-01 2020-06-10 バンタム、ファーマシューティカル、リミテッド、ライアビリティー、カンパニーBantam Pharmaceutical, Llc 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法

Similar Documents

Publication Publication Date Title
JP2007510689A5 (enExample)
RU2426731C2 (ru) Производные арил-изоксазоло-4-ил-оксадиазола
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2016513660A5 (enExample)
RU2012148246A (ru) 5, 7- замещенные-имидазо[1, 2-с]пиримидины как ингибиторы jak-киназ
JP2010533158A5 (enExample)
RU2014152625A (ru) Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
RU2006112046A (ru) Производные пиррола с антибактериальным действием
JP2016526576A5 (enExample)
JP2015517580A5 (enExample)
RU2010150786A (ru) Пирролопиридины как ингибиторы киназы
JP2017525757A5 (enExample)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
JP2006500348A5 (enExample)
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
JP2017508766A5 (enExample)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
CA2729557A1 (en) Chemical compounds 251
JP2010540462A5 (enExample)
IL276575B1 (en) Inhibitors of btk and mutants thereof
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
JP2014528450A5 (enExample)